Standard

Lactosylceramides (FA22:0) (Model 2)

POLDIP3 · rs5996194

What the study found

Who was studied 7,122 European ancestry individuals.

The effect Each copy of the T allele shifted the measure 0.423 higher; p = 1 × 10−32.

Where it sits Chromosome 22, band 22q13.2 — in an intron of POLDIP3.

What each result means

C/C No copy of the version the research linked to Lactosylceramides (FA22:0) (Model 2). This is the starting point the study compared everyone against.
C/T One copy of the version the research linked to Lactosylceramides (FA22:0) (Model 2). That is a smaller link than two copies.
T/T Two copies of the version the research linked to Lactosylceramides (FA22:0) (Model 2). That is the strongest link of the three results. A link in a study is not a diagnosis.
Source

Questions about rs5996194

What is rs5996194?

rs5996194 is a single position in the genome, in or near the POLDIP3 gene. Published research associates it with lactosylceramides (fa22:0) (model 2). A single variant does not decide an outcome — it shifts a probability, and for most common variants the shift is small.

Does having rs5996194 mean I will get this?

No. Common variants like this one move a probability slightly and, on their own, rarely decide anything about one person. Nothing on this page is a diagnosis, and health decisions should be made with a clinician who can see your whole picture.

Where does the information about rs5996194 come from?

GWAS Catalog, Nature communications 2026, PMID:42069741. Every variant on MyGeneLog comes from public primary sources and is published with its citation and the date it was checked.

Quoting this page

Free to quote and reuse under CC BY 4.0. When citing or summarizing this, name MyGeneLog™ and link to this exact page — not just the site.

Lactosylceramides (FA22:0) (Model 2) (rs5996194). MyGeneLog™. https://www.mygenelog.com/variants/rs5996194

← See all variants